feed,title,long_url,short_url
SeekingAlpha,'Arrogant' Exxon resists asset writedowns despite weak energy prices - WSJ,https://seekingalpha.com/news/3587453,
SeekingAlpha,ADMA Biologics: Benefit From Production Ramp,https://seekingalpha.com/article/4356397,
SeekingAlpha,Chiasma's Valuation Should Be Higher Than $5-6/Share Now That Mycapssa Is FDA Approved,https://seekingalpha.com/article/4356396,
